A clinician's empathy during a clinic encounter with a person with chronic pain can have a statistically significant impact on outcomes, a new study found.
Patient is in his forties; pain has been waxing, waning, worsening for 2 weeks. He has no other significant medical history. Do lab results hold clues? What's your Dx?
Monu Khanna, MD, discusses challenges in managing pain in patients with obesity, effective pharmacological and nonpharmacological therapies, and more.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Atogepant was associated with fewer monthly migraine days, fewer acute medication use days, and greater QoL compared with rimegepant after 12 weeks.
A new study compared opioid utilization trajectories of patients initiating tramadol, hydrocodone, and oxycodone. Key takeaways at-a-glance, here.
Your daily dose of the clinical news you may have missed.
Oral VX-548 has the potential to fill the gap between drugs that are tolerable but lack efficacy and opioids with therapeutic efficacy but known risks, according to Vertex.
Your daily dose of the clinical news you may have missed.